Research roundup


Debbie Rigby rounds up the latest in research news Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes This Korean population based cohort study suggests that SGLT-2 inhibitors might prevent dementia, providing greater benefits with longer treatment (more than 2 years). The incidence rates

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Managing symptoms of dry eye
Next Sigma makes offer to get CWH merger approved